<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
IBRX
ImmunityBio
$
()


  • ImmunityBio price target raised by $1 at Piper Sandler, here's why

    3/25/2024 - 06:33am
  • ImmunityBio call volume above normal and directionally bullish

    3/15/2024 - 11:05am
  • Largest borrow rate increases among liquid names

    3/14/2024 - 08:45am
  • Largest borrow rate increases among liquid names

    3/12/2024 - 08:45am
  • Largest borrow rate increases among liquid names

    3/8/2024 - 08:45am
  • ImmunityBio publishes data showing potential to reduce HIV load

    3/5/2024 - 09:26am
  • Largest borrow rate increases among liquid names

    2/29/2024 - 08:45am
  • Largest borrow rate increases among liquid names

    2/28/2024 - 08:45am
  • Unusually active option classes on open February 26th

    2/26/2024 - 09:40am
  • ImmunityBio announces full accrual of first two phases of cancer vaccine trial

    2/21/2024 - 09:20am
  • Largest borrow rate increases among liquid names

    2/21/2024 - 08:45am
  • Largest borrow rate increases among liquid names

    2/12/2024 - 08:45am
  • What You Missed On Wall Street On Monday

    2/5/2024 - 16:26pm
  • What You Missed On Wall Street This Morning

    2/5/2024 - 11:56am
  • ImmunityBio: PROs IN QUILT 3.032 trial indicate stability of physical function

    2/5/2024 - 09:29am
dynamic_feed Breaking News